Charles S. Ryan, Director at BioRestorative Therapies, Inc. (BRTX), bought 6,250 shares at $4.00 ($25K) on 2015-12-07, disclosed to the SEC on 2015-12-17.
Open-market purchase of $25k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |